Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2024

  1. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  3. Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data from the GAMES Series (2008-2021)

    Open Forum Infectious Diseases, Vol. 10, Núm. 8

2022

  1. Abiotrophia spp. and Granulicatella spp. Infective Endocarditis: A Contemporary Perspective

    Frontiers in bioscience (Elite edition), Vol. 14, Núm. 3, pp. 23

  2. Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 279-283

  3. Herpes zoster complicated with aseptic meningitis after cardiac transplantation: Report of two cases and review of the literature

    Revista Espanola de Quimioterapia

  4. Infective endocarditis in children and adolescents: a different profile with clinical implications

    Pediatric Research, Vol. 92, Núm. 5, pp. 1400-1406

2021

  1. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

    Transplant infectious disease : an official journal of the Transplantation Society, Vol. 23, Núm. 3, pp. e13520

  2. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

2020

  1. Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention

    JAC-Antimicrobial Resistance, Vol. 2, Núm. 3

2019

  1. Is it reasonable to perform fecal microbiota transplantation for recurrent clostridium difficile infection in patients with liver cirrhosis?

    Revista Espanola de Quimioterapia

2017

  1. Epidemiology and prognosis of candidaemia in elderly patients

    Mycoses, Vol. 60, Núm. 12, pp. 808-817

2015

  1. Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: A retrospective multicenter case-control study

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 89-95